Literature DB >> 10620555

Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica.

A Escribá1, E Morales, E Albizúa, J C Herrero, T Ortuño, A Carreño, B Dominguez-Gil, M Praga.   

Abstract

Several cases of systemic amyloidosis associated with polymyalgia rheumatica (PMR) or giant-cell arteritis (GCA) have been described. Nevertheless, the type of amyloid deposit has not been characterized in most of them. Here we report on two patients with PMR (one with associated GCA) who developed nephrotic syndrome and end-stage renal failure caused by massive amyloid deposition. Immunohistochemical analysis showed that the amyloid deposits were of AA type (secondary amyloidosis) in both cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620555     DOI: 10.1016/S0272-6386(00)70312-X

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

Review 1.  Currents concepts on the immunopathology of amyloidosis.

Authors:  Anupama Bhat; Carlo Selmi; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

2.  A case of diffuse endocapillary proliferative glomerulonephritis associated with polymyalgia rheumatica.

Authors:  Eri Takeshima; Yoshiyuki Morishita; Manabu Ogura; Chiharu Ito; Osamu Saito; Fumi Takemoto; Yasuhiro Ando; Shigeaki Muto; Wako Yumura; Eiji Kusano
Journal:  Case Rep Nephrol Urol       Date:  2012-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.